TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List November 13, 1998